Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey
The Australian National Health and Medical Research Council (NHMRC) funded Centre for Research Excellence in Women's Health in Reproductive Life (CRE-WHiRL) [APP#1171592].
Authors
- Joop S.E. Laven (ORCID: https://orcid.org/0000-0002-5444-9845)
- Lisa Moran (ORCID: https://orcid.org/0000-0001-5772-6484)
- Helena Jane Teede (ORCID: https://orcid.org/0000-0001-7609-577X)
- Anuja Dokras (ORCID: https://orcid.org/0000-0002-1085-3969)
- Robert J. Norman (ORCID: https://orcid.org/0000-0002-3118-3896)
- Michael Costello (ORCID: https://orcid.org/0000-0001-7340-1356)
- Melanie Gibson‐Helm (ORCID: https://orcid.org/0000-0002-5043-8786)
- Anju E. Joham (ORCID: https://orcid.org/0000-0002-6307-2568)
- Mahnaz Bahri Khomami (ORCID: https://orcid.org/0000-0002-5955-1283)
- Rachel Morman
- Terhi Piltonen (ORCID: https://orcid.org/0000-0002-9921-7300)
- Lorna Berry
Institutions
- Oulu University Hospital (FI)
- ME Association (GB)
- UNSW Sydney (AU)
- Victoria University of Wellington (NZ)
- Monash Health (AU)
- Monash University (AU)
- The University of Adelaide (AU)
- University of Pennsylvania (US)
- University of Oulu (FI)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1016/j.eclinm.2025.103287
- Citations
- 10
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 16.98
Funders
- Amgen
- Veski
- Gedeon Richter
- Novo Nordisk
- State Government of Victoria
- Medical Research Council
- National Health and Medical Research Council